Drug · DIN 01916823
RIDAURA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 17, 2010; first marketed December 31, 1993.
- Drug Identification Number (DIN)
- 01916823
- Company (DIN owner)
- Xediton Pharmaceuticals Inc.Oakville, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Auranofin M01CB03
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| AURANOFIN | 3 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 5, 2010: NOC 11008New Drug Submission (NDS) · Manufacturer name change
- July 15, 2009: NOC 10385New Drug Submission (NDS) · Manufacturer name change
- March 1, 2006: NOC 7792New Drug Submission (NDS) · Manufacturer name change
- November 17, 1999: NOC 1558New Drug Submission (NDS)
- December 8, 1997: NOC 3293New Drug Submission (NDS)